Lincoln Pharmaceuticals
₹586.05
-7.1 (-1.2%)
29 March, 2024 08:02 BSE: 531633
NSE: LINCOLNISIN: INE405C01035
Start SIP in Lincoln Pharmaceuticals
Start SIPLincoln Pharmaceuticals Performance
Day Range
- Low 582
- High 604
52 Week Range
- Low 330
- High 755
- Open Price598
- Previous Close593
- Volume39144
Lincoln Pharmaceuticals Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 146 | 156 | 136 | 112 |
Operating Expenses Qtr Cr | 117 | 125 | 115 | 96 |
Operating Profit Qtr Cr | 30 | 31 | 21 | 17 |
Depreciation Qtr Cr | 3 | 3 | 3 | 2 |
Interest Qtr Cr | 0 | 0 | 0 | 1 |
Tax Qtr Cr | 10 | 9 | 6 | 4 |
Net Profit Qtr Cr | 28 | 28 | 19 | 13 |
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹586.05
-7.1 (-1.2%)
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- ₹613.98
- 50 Day
- ₹631.71
- 100 Day
- ₹616.95
- 200 Day
- ₹563.27
- 20 Day
- ₹617.85
- 50 Day
- ₹646.85
- 100 Day
- ₹640.64
- 200 Day
- ₹552.24
Lincoln Pharmaceuticals Resistance and Support
PIVOT
₹590.67
Resistance | |
---|---|
First Resistance | 599.23 |
Second Resistance | 612.42 |
Third Resistance | 620.98 |
RSI | 38.43 |
MFI | 31.08 |
MACD Single Line | -18.14 |
MACD | -18.74 |
Support | |
---|---|
First Resistance | 577.48 |
Second Resistance | 568.92 |
Third Resistance | 555.73 |
Lincoln Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 41,324 | 2,676,142 | 64.76 |
Week | 45,282 | 2,679,306 | 59.17 |
1 Month | 87,145 | 4,647,430 | 53.33 |
6 Month | 146,157 | 5,426,820 | 37.13 |
Lincoln Pharmaceuticals Result Highlights
Lincoln Pharmaceuticals Synopsis
NSE-Medical-Diversified
Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 510.31 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2023. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.Market Cap | 1,174 |
Sales | 551 |
Shares in Float | 1.00 |
No of funds | 24 |
Yield | 0.25 |
Book Value | 2.34 |
U/D Vol ratio | 0.8 |
LTDebt / Equity | |
Alpha | 0.15 |
Beta | 0.87 |
Lincoln Pharmaceuticals
Owner Name | Dec-23 | Sep-23 | Jun-23 | Mar-23 |
---|---|---|---|---|
Promoters | 49.8% | 50.53% | 48.67% | 47% |
Mutual Funds | ||||
Foreign Portfolio Investors | 3.22% | 2.59% | 1.74% | 1.27% |
Individual Investors | 37.78% | 37.47% | 37.32% | 37.04% |
Others | 9.2% | 9.41% | 12.27% | 14.69% |
Lincoln Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Kishor M Shah | Chairman |
Mr. Mahendra G Patel | Managing Director |
Mr. Hashmukh I Patel | Whole Time Director |
Mr. Munjal M Patel | Whole Time Director |
Mr. Ashish R Patel | Whole Time Director |
Mr. Rajnikant G Patel | Non Executive Director |
Mr. Meha M Patel | Independent Director |
Mr. Saurin J Parikh | Independent Director |
Mr. Pirabhai R Suthar | Independent Director |
Lincoln Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Lincoln Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-08 | Quarterly Results | |
2023-11-02 | Quarterly Results | |
2023-08-10 | Quarterly Results | |
2023-05-25 | Audited Results & Dividend | |
2023-02-09 | Quarterly Results |
Lincoln Pharmaceuticals FAQs
What is Share Price of Lincoln Pharmaceuticals ?
Lincoln Pharmaceuticals share price is ₹586 As on 29 March, 2024 | 07:48
What is the Market Cap of Lincoln Pharmaceuticals ?
The Market Cap of Lincoln Pharmaceuticals is ₹1173.8 Cr As on 29 March, 2024 | 07:48
What is the P/E ratio of Lincoln Pharmaceuticals ?
The P/E ratio of Lincoln Pharmaceuticals is 13.5 As on 29 March, 2024 | 07:48
What is the PB ratio of Lincoln Pharmaceuticals ?
The PB ratio of Lincoln Pharmaceuticals is 2.3 As on 29 March, 2024 | 07:48